譜尼測試(300887.SZ):實驗室擁有先進的試驗設備和測試儀器上千台套,具備 CNAS、CMA資質及軍工檢測相關證書
格隆匯6月12日丨譜尼測試(300887.SZ)在投資者互動平台表示,公司實驗室擁有先進的試驗設備和測試儀器上千台套,具備 CNAS、CMA資質及軍工檢測相關證書。可針對各類裝備產品開展環境試驗、可靠性試驗、電磁兼容檢測、軟件測評、可靠性試驗方案設計與制定、產品通用質量特性研究等一站式綜合檢測與技術支撐,服務於汽車、軌道交通、航空、航天、船舶、網絡通信等領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.